GLOBAL H1N1 VACCINES MARKET 2011-2015
TechNavio's analysts forecast the Global H1N1 Vaccines market to
decline at a CAGR of -33 percent over the period 2011-2015.
To Browse This Report Click :
• TechNavio's analysts forecast the Global H1N1 Vaccines market to decline at a
CAGR of -33 percent over the period 2011-2015. One of the key factors
contributing to this market growth is the increased awareness among people
in developed nations. The Global H1N1 Vaccines market has also been
witnessing the trend of Pre-pandemic vaccinations. However, the easing
pandemic situation could pose a challenge to the growth of this market.
TechNavio's report, the Global H1N1 Vaccines Market 2011-2015, has been
prepared based on an in-depth market analysis with inputs from industry
experts. The report covers the Americas, and the EMEA and APAC regions; it
also covers the Global H1N1 Vaccines market landscape and its growth
prospects in the coming years. The report also includes a discussion of the
key vendors operating in this market.
The key vendors dominating this market space are AstraZeneca plc.,
GlaxoSmithKline plc., Merck and Co. Inc., Novartis AG, Sanofi AG.
To Browse This Report:
KEY QUESTIONS ANSWERED IN
• What will the market size be in 2015 and what will the growth rate
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key
• What are the strengths and weaknesses of the key vendors?
TABLE OF CONTENT
• 1. Executive Summary
• 2. Introduction
• 3. Market Coverage
• Market Overview
• Key Offerings
• 4. Market Landscape
• 4.1 Global H1N1 Vaccines Market
• Market Size and Forecast
• 4.2 Global H1N1 Vaccines Market by Route of Administration
• 4.3 Five Forces Analysis
• 5. Geographical Segmentation
• 6. Rate of Incidence and Prevalence
• 7. Vendor Landscape
• 8. Buying Criteria
• 9. Market Growth Drivers
• 10. Drivers and their Impact
11. Market Challenges
• 12. Impact of Drivers and Challenges
• 13. Market Trends
• 14. Key Vendor Analysis
14.1 GlaxoSmithKline plc
14.2 Merck and Co. Inc.
14.3 Sanofi S.A.
14.4 AstraZeneca plc
14. Other Reports in this Series
Exhibit 1: The Global H1N1 Vaccines Market 2011-2015 (US$ millions)
Exhibit 2: Global H1N1 Vaccines Market by Geographical Segmentation
Exhibit 3: Global H1N1 Vaccines Market by Vendor Segmentation 2011
We are a one stop solution for CONTACT INFORMATION
all your research needs.
To Browse This Report: Click Below Link
To Browse All Reports of this Publisher : Click Below Link
To Browse All Reports : Visit